We are delighted to announce that SinoMedCare BioTech Co., Ltd. (SMC) has become the exclusive distributor of our vibrating mesh nebulizer Pulmogine^® in China.

For the launch ceremony of Pulmogine^® on Oct. 15th, professors from Southern Medical University and Shanghai Jiao Tong University were invited to attend the event as speaking guests. In the speech, it was mentioned that low adherence to a certain treatment can potentially lower the effectiveness of the medications and worsen control over respiratory diseases. By providing a device that is easy to use and easy to carry around, we hope to increase patients’ will to use the nebulizer, hence enhancing treatment adherence.

During the event, we also had the chance to introduce the mechanism of Pulmogine^®. Equipped with a newly developed technology (Micro Synchronized Delivery Technology, MSDT), Pulmogine^® is able to nebulize different types of medications with low drug residue and aerosols droplet size within a desirable range for better lung deposition. With the introduction of Pulmogine^® to the China market, we hope to provide patients the chance to experience a new way of receiving treatment and enhance their quality of life.
 

---